-
公开(公告)号:US20230348865A1
公开(公告)日:2023-11-02
申请号:US17996921
申请日:2021-04-23
Applicant: Genomatica, Inc.
Inventor: Amit Mahendra SHAH , Deqiang ZHANG , Joseph Roy WARNER , Benjamin Matthew GRIFFIN , Russell Scott KOMOR , Harish NAGARAJAN , Sankha GHATAK , Toby Howard RICHARDSON
CPC classification number: C12N9/0008 , C12Y102/0103 , C12P13/001 , C12P7/04 , C12N15/52 , C12N9/1029 , C12Y203/01174 , C12Y102/01003 , C12N9/88 , C12Y402/01017 , C12N9/1096
Abstract: The invention provides an engineered carboxylic acid reductase (CAR) enzyme, a nucleic acid encoding the CAR enzyme, and a non-naturally occurring microbial organism comprising an exogenous nucleic acid encoding the CAR, an engineered transaminase (TA) enzyme, and/or a hexamethylenediamine (HMD) transaminase (TA2) enzyme. The invention provides a non-naturally occurring microbial organism that has a 1,6-hexanediol (HDO) pathway with a HDO pathway enzyme expressed in sufficient amounts to produce 6 aminocaproate semi aldehyde, HDO, or both. The invention further provides a non-naturally occurring microbial organism that has an HMD pathway with a HMD pathway enzyme expressed in sufficient amounts to produce 6-aminocaproate semialdehyde, HMD, or both. The invention additionally provides bioderived HMD, 6-aminocaproate semialdehyde, and/or HDO and methods for producing bioderived HMD, 6-aminocaproate semialdehyde, and/or HDO.
-
公开(公告)号:US20230287464A1
公开(公告)日:2023-09-14
申请号:US17749529
申请日:2022-05-20
Applicant: Genomatica, Inc.
Inventor: Priti Pharkya , Anthony P. Burgard , Mark J. Burk
IPC: C12P5/02 , C12N15/52 , C12P3/00 , C12P7/40 , C01B3/00 , C08F36/06 , C08F36/14 , C12N9/04 , C12N9/02 , C12N9/10 , C12N9/12
CPC classification number: C12P5/026 , C01B3/00 , C08F36/06 , C08F36/14 , C12N9/0006 , C12N9/0008 , C12N9/10 , C12N9/12 , C12N9/0067 , C12N15/52 , C12P3/00 , C12P7/40 , C12Y101/02007 , C12Y101/03013 , C12Y102/99003 , Y02E50/30 , Y02E60/32
Abstract: The invention provides non-naturally occurring microbial organisms containing butadiene or 2,4-pentadienoate pathways comprising at least one exogenous nucleic acid encoding a butadiene or 2,4-pentadienoate pathway enzyme expressed in a sufficient amount to produce butadiene or 2,4-pentadienoate. The organism can further contain a hydrogen synthesis pathway. The invention additionally provides methods of using such microbial organisms to produce butadiene or 2,4-pentadienoate by culturing a non-naturally occurring microbial organism containing butadiene or 2,4-pentadienoate pathways as described herein under conditions and for a sufficient period of time to produce butadiene or 2,4-pentadienoate. Hydrogen can be produced together with the production of butadiene or 2,4-pentadienoate.
-
公开(公告)号:US20230287435A1
公开(公告)日:2023-09-14
申请号:US17772990
申请日:2020-10-28
Applicant: Genomatica, Inc.
Inventor: Harish Nagarajan , Gionata Scalcinati , Tae Hoon Yang
CPC classification number: C12N15/52 , C12P7/18 , C12Y202/01006 , C12Y104/99001 , C12Y501/01001 , C12Y102/01003 , C12Y602/01001 , C12Y203/03001
Abstract: The present disclosure provides microbial organisms having decreased production of unwanted by-products (e.g, pyruvate-, CO2—, TCA-derived by-products; acetate; ethanol; and/or, alanine) to enhance carbon flux through acetyl-CoA, which can increase production of acetyl-CoA derived compounds (e.g, 1,3-BDO, MMA, and (3R)-hydroxybutyl (3R)-hydroxybutyrate, or any other acetyl-CoA derived compounds), and products made from any of these compounds. Also provided are one or more exogenous nucleic acids encoding enzymes that can decrease production of unwanted by-products (e.g, aldehyde dehydrogenase, acetyl-CoA synthase, amino acid dehydrogenase, alanine racemase, and/or citrate synthase), and/or one or more gene attenuations occurring in genes (e.g., acetolactate synthase) that result in decreased production of unwanted by-products. Various combinations of the exogenous nucleic acids and gene deletions are also provided in the present disclosure. Methods of making and using the same, including methods for culturing cells, and for the production of the various products are also provided.
-
公开(公告)号:US20230167468A1
公开(公告)日:2023-06-01
申请号:US17995778
申请日:2021-04-13
Applicant: GENOMATICA, INC.
CPC classification number: C12P7/42 , C12N9/0004 , C12Y121/03008 , C12Y121/03007 , C12P17/06 , C12P7/22
Abstract: The invention relates to a non-natural cannabinoid synthase comprising at least one amino acid variation as compared to a wild type cannabinoid synthase Δ9-tetrahydrocannabinolic acid synthase (THCAS), comprising three alpha helices (αA, αB and αC) where a disulfide bond is not formed between alpha helix αA and alpha helix αC, wherein the non-natural cannabinoid synthase catalyzes the oxidative cyclization of cannabigerolic acid (CBGA) into a cannabinoid. The invention further relates to a non-natural Δ9-tetrahydrocannabinolic acid synthase (THCAS), a non-natural cannabidiolic acid synthase (CBDAS), and a non-natural cannabichromenic acid synthase (CBCAS) comprising at least one amino acid variation as compared to a wild type THCAS, CBDAS, or CBCAS, respectively, comprising three alpha helices (αA, αB and αC) and wherein a disulfide bond is not formed between alpha helix αA and alpha helix αC. The invention also relates to a nucleic acid, expression construct, and engineered cell for making the non-natural THCAS, CBDAS, and/or CBCAS. Also provided are compositions comprising the non-natural THCAS, CBDAS, and/or CBCAS; isolated non-natural THCAS, CBDAS, and/or CBCAS enzymes; methods of making the isolated enzymes; cell extracts comprising cannabinoids; and methods of making cannabinoids.
-
公开(公告)号:US20230159901A1
公开(公告)日:2023-05-25
申请号:US17834681
申请日:2022-06-07
Applicant: Genomatica, Inc.
Inventor: Andreas SCHIRMER , Baolong ZHU , Emanuela POPOVA
CPC classification number: C12N9/0006 , C12N15/62 , C12N9/0042 , C12N15/81 , C07K2319/00 , C12N9/18
Abstract: The disclosure relates to omega-hydroxylase-related fusion polypeptides that result in improved omega-hydroxylated fatty acid derivative production when expressed in recombinant host cells. The disclosure further relates to microorganisms for expressing the omega-hydroxylase-related fusion polypeptides for the production of omega-hydroxylated fatty acid derivatives.
-
公开(公告)号:US20230134936A1
公开(公告)日:2023-05-04
申请号:US17749015
申请日:2022-05-19
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Stephen J. Van Dien , Anthony P. Burgard , Wei Niu
IPC: C12N15/52 , C12N9/04 , C12N9/02 , C12N9/88 , C12N9/00 , C12P7/52 , C12P17/04 , B01D3/00 , C12P7/18 , C12P7/42 , C12N15/70 , C12N15/81
Abstract: The invention provides a non-naturally occurring microbial biocatalyst including a microbial organism having a 4-hydroxybutanoic acid (4-HB) biosynthetic pathway having at least one exogenous nucleic acid encoding 4-hydroxybutanoate dehydrogenase, succinyl-CoA synthetase, CoA-dependent succinic semialdehyde dehydrogenase, or α-ketoglutarate decarboxylase, wherein the exogenous nucleic acid is expressed in sufficient amounts to produce monomeric 4-hydroxybutanoic acid (4-HB). Also provided is a non-naturally occurring microbial biocatalyst including a microbial organism having 4-hydroxybutanoic acid (4-HB) and 1,4-butanediol (BDO) biosynthetic pathways, the pathways include at least one exogenous nucleic acid encoding 4-hydroxybutanoate dehydrogenase, succinyl-CoA synthetase, CoA-dependent succinic semialdehyde dehydrogenase, 4-hydroxybutyrate:CoA transferase, 4-butyrate kinase, phosphotransbutyrylase, α-ketoglutarate decarboxylase, aldehyde dehydrogenase, alcohol dehydrogenase or an aldehyde/alcohol dehydrogenase, wherein the exogenous nucleic acid is expressed in sufficient amounts to produce 1,4-butanediol (BDO). Additionally provided are methods for the production of 4-HB and BDO.
-
公开(公告)号:US11634692B2
公开(公告)日:2023-04-25
申请号:US17280181
申请日:2019-09-25
Applicant: GENOMATICA, INC.
Inventor: Amit Shah , Joseph Warner
Abstract: The invention provides polypeptides and encoding nucleic acids of aldehyde dehydrogenase variants. The invention also provides cells expressing aldehyde dehydrogenase variants. The invention further provides methods for producing 3-hydroxybutyraldehyde (3-HBal) and/or 1,3-butanediol (1,3-BDO), or an ester or amide thereof, comprising culturing cells expressing an aldehyde dehydrogenase variant or using lysates of such cells. The invention additional provides methods for producing 4-hydroxybutyraldehyde (4-HBal) and/or 1,4-butanediol (1,4-BDO), or an ester or amide thereof, comprising culturing cells expressing an aldehyde dehydrogenase variant or using lysates of such cells.
-
88.
公开(公告)号:US20230022727A1
公开(公告)日:2023-01-26
申请号:US17527902
申请日:2021-11-16
Applicant: Genomatica, Inc.
Inventor: Mark J. Burk , Anthony P. Burgard , Robin E. Osterhout , Priti Pharkya
Abstract: The invention provides a non-naturally occurring microbial organism having a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway. The invention additionally provides a method for producing 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid. The method can include culturing a 6-aminocaproic acid, caprolactam or hexametheylenediamine producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding a 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce 6-aminocaproic acid, caprolactam, hexametheylenediamine or levulinic acid.
-
公开(公告)号:US11384341B2
公开(公告)日:2022-07-12
申请号:US17001015
申请日:2020-08-24
Applicant: Genomatica, Inc.
Inventor: Andreas Schirmer , Baolong Zhu , Emanuela Popova
Abstract: The disclosure relates to omega-hydroxylase-related fusion polypeptides that result in improved omega-hydroxylated fatty acid derivative production when expressed in recombinant host cells. The disclosure further relates to microorganisms for expressing the omega-hydroxylase-related fusion polypeptides for the production of omega-hydroxylated fatty acid derivatives.
-
公开(公告)号:US20220090028A1
公开(公告)日:2022-03-24
申请号:US17405685
申请日:2021-08-18
Applicant: Genomatica, Inc.
Inventor: Mathew RUDE , Na TRINH , Andreas SCHIRMER , Jacob GANO
Abstract: The disclosure relates to acyl-ACP reductase (AAR) enzyme variants that result in improved fatty aldehyde and fatty alcohol production when expressed in recombinant host cells. The disclosure further relates to methods of making and using such AAR variants for the production of fatty alcohol compositions having particular characteristics.
-
-
-
-
-
-
-
-
-